Table 4.
Variables | Strong CDK14 staining (n = 129) | Weak CDK14 staining (n = 64) | P |
---|---|---|---|
Age, years | 53.27 ± 11.93 | 52.46 ± 10.82 | 0.648 |
BMI, kg/m2 | 22.85 ± 3.03 | 22.54 ± 3.02 | 0.509 |
Sex, male:female (%) | 78 (60.47):51 (39.53) | 41 (64.06):23 (35.94) | 0.600 |
Current smoker, n (%) | 69 (53.49) | 38 (59.38) | 0.401 |
TNM stage, n (%) | <0.001 | ||
I–II | 48 (37.21) | 41 (64.06) | |
III–IV | 81 (62.79) | 23 (35.94) | |
Pathological type, n (%) | 0.018 | ||
Squamous cell carcinoma | 78 (60.47) | 28 (43.75) | |
Adenocarcinoma | 51 (39.53) | 36 (56.25) | |
Pleural invasion, n (%) | 79 (76.70) | 24 (37.50) | <0.001 |
Lymph node metastasis, n (%) | 97 (75.19) | 31 (48.44) | <0.001 |
5-year survival, n (%) | 9 (6.98) | 11 (17.19) | 0.027 |
CDK14, cyclin-dependent kinase 14; BMI, body mass index.